Cargando…

Lessons Learned From Managing the Planning and Implementation of Inactivated Polio Vaccine Introduction in Support of the Polio Endgame

The Immunization Systems Management Group (IMG) was established as a time-limited entity, responsible for the management and coordination of Objective 2 of the Polio Eradication and Endgame Strategic Plan. This objective called for the introduction of at least 1 dose of inactivated polio vaccine (IP...

Descripción completa

Detalles Bibliográficos
Autores principales: Zipursky, Simona, Patel, Manish, Farrell, Margaret, Gonzalez, Alejandro Ramirez, Kachra, Tasleem, Folly, Yann, Kurji, Feyrouz, Veira, Chantal Laroche, Wootton, Emily, Hampton, Lee M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853318/
https://www.ncbi.nlm.nih.gov/pubmed/28838203
http://dx.doi.org/10.1093/infdis/jix185
_version_ 1783306740645756928
author Zipursky, Simona
Patel, Manish
Farrell, Margaret
Gonzalez, Alejandro Ramirez
Kachra, Tasleem
Folly, Yann
Kurji, Feyrouz
Veira, Chantal Laroche
Wootton, Emily
Hampton, Lee M.
author_facet Zipursky, Simona
Patel, Manish
Farrell, Margaret
Gonzalez, Alejandro Ramirez
Kachra, Tasleem
Folly, Yann
Kurji, Feyrouz
Veira, Chantal Laroche
Wootton, Emily
Hampton, Lee M.
author_sort Zipursky, Simona
collection PubMed
description The Immunization Systems Management Group (IMG) was established as a time-limited entity, responsible for the management and coordination of Objective 2 of the Polio Eradication and Endgame Strategic Plan. This objective called for the introduction of at least 1 dose of inactivated polio vaccine (IPV) into the routine immunization programs of all countries using oral polio vaccine (OPV) only. Despite global vaccine shortages, which limited countries’ abilities to access IPV in a timely manner, 105 of 126 countries using OPV only introduced IPV within a 2.5-year period, making it the fastest rollout of a new vaccine in history. This achievement can be attributed to several factors, including the coordination work of the IMG; high-level engagement and advocacy across partners; the strong foundations of the Expanded Programme on Immunization at all levels; Gavi, the Vaccine Alliance’s vaccine introduction experiences and mechanisms; innovative approaches; and proactive communications. In many ways, the IMG’s work on IPV introduction can serve as a model for other vaccine introductions, especially in an accelerated context.
format Online
Article
Text
id pubmed-5853318
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-58533182018-07-01 Lessons Learned From Managing the Planning and Implementation of Inactivated Polio Vaccine Introduction in Support of the Polio Endgame Zipursky, Simona Patel, Manish Farrell, Margaret Gonzalez, Alejandro Ramirez Kachra, Tasleem Folly, Yann Kurji, Feyrouz Veira, Chantal Laroche Wootton, Emily Hampton, Lee M. J Infect Dis Supplement Article The Immunization Systems Management Group (IMG) was established as a time-limited entity, responsible for the management and coordination of Objective 2 of the Polio Eradication and Endgame Strategic Plan. This objective called for the introduction of at least 1 dose of inactivated polio vaccine (IPV) into the routine immunization programs of all countries using oral polio vaccine (OPV) only. Despite global vaccine shortages, which limited countries’ abilities to access IPV in a timely manner, 105 of 126 countries using OPV only introduced IPV within a 2.5-year period, making it the fastest rollout of a new vaccine in history. This achievement can be attributed to several factors, including the coordination work of the IMG; high-level engagement and advocacy across partners; the strong foundations of the Expanded Programme on Immunization at all levels; Gavi, the Vaccine Alliance’s vaccine introduction experiences and mechanisms; innovative approaches; and proactive communications. In many ways, the IMG’s work on IPV introduction can serve as a model for other vaccine introductions, especially in an accelerated context. Oxford University Press 2017-07-01 2017-07-01 /pmc/articles/PMC5853318/ /pubmed/28838203 http://dx.doi.org/10.1093/infdis/jix185 Text en © The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. https://creativecommons.org/licenses/by/3.0/igo/ This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 IGO (CC BY 3.0 IGO) License (https://creativecommons.org/licenses/by/3.0/igo/) which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Supplement Article
Zipursky, Simona
Patel, Manish
Farrell, Margaret
Gonzalez, Alejandro Ramirez
Kachra, Tasleem
Folly, Yann
Kurji, Feyrouz
Veira, Chantal Laroche
Wootton, Emily
Hampton, Lee M.
Lessons Learned From Managing the Planning and Implementation of Inactivated Polio Vaccine Introduction in Support of the Polio Endgame
title Lessons Learned From Managing the Planning and Implementation of Inactivated Polio Vaccine Introduction in Support of the Polio Endgame
title_full Lessons Learned From Managing the Planning and Implementation of Inactivated Polio Vaccine Introduction in Support of the Polio Endgame
title_fullStr Lessons Learned From Managing the Planning and Implementation of Inactivated Polio Vaccine Introduction in Support of the Polio Endgame
title_full_unstemmed Lessons Learned From Managing the Planning and Implementation of Inactivated Polio Vaccine Introduction in Support of the Polio Endgame
title_short Lessons Learned From Managing the Planning and Implementation of Inactivated Polio Vaccine Introduction in Support of the Polio Endgame
title_sort lessons learned from managing the planning and implementation of inactivated polio vaccine introduction in support of the polio endgame
topic Supplement Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853318/
https://www.ncbi.nlm.nih.gov/pubmed/28838203
http://dx.doi.org/10.1093/infdis/jix185
work_keys_str_mv AT zipurskysimona lessonslearnedfrommanagingtheplanningandimplementationofinactivatedpoliovaccineintroductioninsupportofthepolioendgame
AT patelmanish lessonslearnedfrommanagingtheplanningandimplementationofinactivatedpoliovaccineintroductioninsupportofthepolioendgame
AT farrellmargaret lessonslearnedfrommanagingtheplanningandimplementationofinactivatedpoliovaccineintroductioninsupportofthepolioendgame
AT gonzalezalejandroramirez lessonslearnedfrommanagingtheplanningandimplementationofinactivatedpoliovaccineintroductioninsupportofthepolioendgame
AT kachratasleem lessonslearnedfrommanagingtheplanningandimplementationofinactivatedpoliovaccineintroductioninsupportofthepolioendgame
AT follyyann lessonslearnedfrommanagingtheplanningandimplementationofinactivatedpoliovaccineintroductioninsupportofthepolioendgame
AT kurjifeyrouz lessonslearnedfrommanagingtheplanningandimplementationofinactivatedpoliovaccineintroductioninsupportofthepolioendgame
AT veirachantallaroche lessonslearnedfrommanagingtheplanningandimplementationofinactivatedpoliovaccineintroductioninsupportofthepolioendgame
AT woottonemily lessonslearnedfrommanagingtheplanningandimplementationofinactivatedpoliovaccineintroductioninsupportofthepolioendgame
AT hamptonleem lessonslearnedfrommanagingtheplanningandimplementationofinactivatedpoliovaccineintroductioninsupportofthepolioendgame